Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
51.4M
-
Number of holders
-
38
-
Total 13F shares, excl. options
-
16.5M
-
Shares change
-
+16.5M
-
Total reported value, excl. options
-
$166M
-
Value change
-
+$166M
-
Number of buys
-
37
-
Price
-
$10.06
Significant Holders of Mirum Pharmaceuticals, Inc. - Common Stock (MIRM) as of Q3 2019
38 filings reported holding MIRM - Mirum Pharmaceuticals, Inc. - Common Stock as of Q3 2019.
Mirum Pharmaceuticals, Inc. - Common Stock (MIRM) has 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.5M shares
of 51.4M outstanding shares and own 32.1% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (4.19M shares), FRAZIER MANAGEMENT LLC (3.57M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (3.45M shares), Novo Holdings A/S (2.45M shares), ALLIANCEBERNSTEIN L.P. (1.14M shares), Rock Springs Capital Management LP (790K shares), BAKER BROS. ADVISORS LP (333K shares), MILLENNIUM MANAGEMENT LLC (125K shares), VANGUARD GROUP INC (81.9K shares), and Alyeska Investment Group, L.P. (75.2K shares).
This table shows the top 38 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.